The present invention is based, in part, on assays we conducted that revealed compounds that may be used to treat or prevent diseases characterized by an abnormal or undesirable association of one protein with another.

 
Web www.patentalert.com

< Dosage forms and related therapies

< Bicyclic heterocycles as kinase inhibitors

> Melanocortin receptor ligands

> Combination of proton pump inhibitor, buffering agent, and prokinetic agent
~ 00217